Who owns BRISTOL MYERS SQUIBB CO (BMY)? Elite investor 13F holders

13 tracked elite investors reported holding BRISTOL MYERS SQUIBB CO as of 2026-06-30, including Pzena Investment Management, Dodge & Cox Funds, Gotham Asset Management, Ariel Investments, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

13 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Pzena Investment ManagementBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-07 00:00:00979945875.00 USD17007044.000000SharesreduceOriginal filing
Dodge & Cox FundsBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-13 00:00:002440822.00 USD42361.000000SharesreduceOriginal filing
Renaissance Technologies LLCBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-13 00:00:000.00 USD0.000000SharesexitedOriginal filing
Gotham Asset ManagementBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-14 00:00:0051452874.00 USD892969.000000SharesaddOriginal filing
Ariel InvestmentsBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-14 00:00:0040128297.00 USD696430.000000SharesreduceOriginal filing
D.E. ShawBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-14 00:00:0032233031.00 USD559407.000000SharesaddOriginal filing
GMOBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-13 00:00:0023709650.00 USD411483.000000SharesreduceOriginal filing
Bridgewater AssociatesBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing
Kahn Brothers GroupBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-17 00:00:0010034638.00 USD174152.000000SharesaddOriginal filing
GAMCOBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-12 00:00:004763503.00 USD82671.000000SharesreduceOriginal filing
Miller Value PartnersBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-14 00:00:004004590.00 USD69500.000000SharesholdOriginal filing
Hillman Capital ManagementBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-14 00:00:002606441.00 USD45235.000000SharesreduceOriginal filing
Tweedy BrowneBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-07 00:00:002164783.00 USD37570.000000SharesaddOriginal filing
Ancora Advisors / Ancora HoldingsBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-14 00:00:001386809.00 USD24068.000000SharesreduceOriginal filing
Mairs & Power FundsBRISTOL MYERS SQUIBB COSHARE2026-06-302026-08-14 00:00:001422292.00 USD24684.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown